Want to hire this expert for a project? Request a quote for free.
Profile Details
Hire Dr. Sean V.
Canada
PhD Biochemistry | Expert in pharmaceuticals, clinical trials, oncology and stem cells
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing,
Newswriting,
General Proofreading & Editing
Research
Meta-Research,
Feasibility Study,
Technology Scouting,
Fact Checking,
Gap Analysis,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Business Strategy Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Image Processing,
Image Analysis,
Data Cleaning,
Data Processing
Work Experience
Postdoctoral Researcher
McMaster University
- Present ![]()
Postdoctoral Researcher
McMaster University
January 2025 - Present
Clinical Trial Manager
Kingsman Scientific Management
May 2019 - September 2020
Education
PhD, Biochemistry
McMaster University
September 2019 - December 2024
Masters of Biomedical Technology
Univerity of Calgary
September 2018 - August 2019
Bachelors in Science (Biochemistry)
McMaster University
September 2013 - April 2018
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Kinga Vojnits, Zhuohang Feng, Paige Johnson, Deanna Porras, Ekta Manocha, Sean Vandersluis, Sibylle Pfammatter, Pierre Thibault, Mick Bhatia (2024). Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs . Cancer Letters.
Allison L. Boyd, Justin Lu, Cameron G. Hollands, Lili Alsostovar, Shiva Murali, Jennifer C. Reid, Wendy Ye, Sean Vandersluis, Paige Johnson, Amro ElRafie, et al. (2023). Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia . Cell Reports Medicine.
Sean Vandersluis, Jennifer C. Reid, Luca Orlando, Mickie Bhatia (2022). Evidence-based support for phenotypic drug discovery in acute myeloid leukemia . Drug Discovery Today.